Asia Pacific Genomics Market Size, Share, and COVID-19 Impact Analysis, By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, and Others), By Application (Diagnostics, Research, and Others), and Asia Pacific Genomics Market Insights, Industry Trend, Forecasts to 2035

Asia Pacific Genomics Market Insights Forecasts to 2035

• The Asia Pacific Genomics Market Size was Estimated at USD 7.26 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 17.93% from 2025 to 2035
• The Asia Pacific Genomics Market Size is Expected to Reach USD 44.55 Billion by 2035

The Asia Pacific Genomics Market is anticipated to reach USD 44.55 Billion by 2035, growing at a CAGR of 17.93% from 2025 to 2035. Technological advancements in genome sequencing, along with an increasing demand for healthcare testing, are significantly contributing to driving the genomics market in the Asia Pacific region.

Market Overview

The Asia Pacific genomics market refers to the industry that emphasizes the study and use of an organism’s genome. Genomics refers to the study of all of a person’s genes (the genome), including interactions of those genes with each other and with the person’s environment. There is an upsurging market demand for genomics, which is primarily driven by a surge in the prevalence of viral and inherited disorders that demand genomic sequencing. There is an increasing adoption of personalized medicine, which includes tailored treatment plans based on genomic data, that ultimately enhance patient outcomes. An increasing application of genomics in precision medicine, with the ever-growing correlation between diseases and genetics, is escalating the market growth opportunity.

Report Coverage

This research report categorizes the market for the Asia Pacific genomics market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific genomics market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific genomics market.

Driving Factors

Technological advancements in genome sequencing, which are transforming the field of genomics, are contributing to driving the market growth. The growing demand for genomic screening as part of routine check-ups is propelling the market demand. Further, an increasing adoption of personalized medicine as well as growing prevalence of chronic & genetic diseases are driving the genomics market. Further, the substantial growth in sequencing technology, driven by advancements in next-generation sequencing, is contributing to market growth.

Restraining Factors

The shortage of trained workforce and increased cost of instruments are limiting the adoption of the genomics concept is challenging the market. Further, the data privacy and security concerns related to genetic data are hampering the market growth.

Market Segmentation

The Asia Pacific genomics market share is classified into technology and application.

• The polymerase chain reaction (PCR) segment held the maximum market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific genomics market is segmented by technology into polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, sanger sequencing, and others. Among these, the polymerase chain reaction (PCR) segment held the maximum market share in 2024 and is expected to grow at a significant CAGR during the forecast period. PCR is increasingly being used in routine pathology services for cancer biomarker detection and newborn genetic screening. The prominent use and accessibility of polymerase chain reaction (PCR) are driving the genomics market growth.

•  The diagnostics segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific genomics market is segmented by application into diagnostics, research, and others. Among these, the diagnostics segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Genomic technologies such as DNA sequencing and gene expression profiling are used for the diagnosis of various conditions, such as inherited disorders, infectious diseases, and cancers. The emergence of direct-to-consumer genetic testing and the use of NGS technology are propelling the market growth in the diagnostics segment.

•  Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific genomics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Danaher Corporation
• Agilent Technologies, Inc.
• Hoffmann-La Roche Ltd.
• Eurofins Scientific Group
• New England BioLabs, Inc.
• Roche Diagnostics
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific Genomics Market based on the below-mentioned segments:

Asia Pacific Genomics Market, By Technology

• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Microarray
• Sanger Sequencing
• Others

Asia Pacific Genomics Market, By Application

• Diagnostics
• Research
• Others